Sono-Tek Corporation reported financial results for the second quarter and first half of fiscal year 2026, ending August 31, 2025. The company recorded its sixth consecutive quarter with revenue exceeding $5 million and reported a 150% year-over-year increase in medical market sales. Fiscal first half net income rose 35%. The order backlog increased 50% sequentially. US/Canada sales decreased by $324,000, or 5% year-over-year, mainly due to lower demand in the clean energy sector. In Asia, sales increased by $647,000, or 74%, led by medical sales in China and alternative energy sales in Japan and South Korea. EMEA sales declined by $60,000, and Latin American sales decreased by $160,000, influenced by lower fluxing sales in Mexico. As of August 31, 2025, Sono-Tek held $10.6 million in cash, cash equivalents, and marketable securities, with no debt and stockholders' equity of $18.7 million. Capital expenditures for the first half of fiscal 2026 totaled $113,000. The company expects capital expenditures for the full fiscal year to reach approximately $300,000.